Biotechnology in Japan

Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Japan biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

The Japanese biotechnology market is expected to generate total revenues of $35.6bn in 2015, representing a compound annual growth rate (CAGR) of 3.4% between 2011 and 2015.

The environment & industrial processing segment is expected to be the market's most lucrative in 2015, with total revenues of $12.2bn, equivalent to 34.3% of the market's overall value.

The Japanese government has invested significantly in the biotech industry, partly in response to China’s aim of overtaking Japan as a regional center for the industry. In 2014, the government set aside approximately $165bn for cancer initiatives as well as further investment in the creation of a pilot factory for biologic drugs.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Japan

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Japan

Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Japan biotechnology market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Japan economy

Reasons to buy

What was the size of the Japan biotechnology market by value in 2015?

What will be the size of the Japan biotechnology market in 2020?

What factors are affecting the strength of competition in the Japan biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up Japan's biotechnology market?

Companies mentioned

Astellas Pharma Inc., Daiichi Sankyo Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Company Limited

Table of Contents

TABLE OF CONTENTS

Executive Summary 2

Market value 2

Market value forecast 2

Category segmentation 2

Geography segmentation 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 8

Market value 8

Market Segmentation 9

Category segmentation 9

Geography segmentation 10

Market Outlook 11

Market value forecast 11

Five Forces Analysis 12

Summary 12

Buyer power 13

Supplier power 14

New entrants 15

Threat of substitutes 17

Degree of rivalry 18

Leading Companies 19

Astellas Pharma Inc. 19

Daiichi Sankyo Co., Ltd. 22

Mitsubishi Tanabe Pharma Corporation 25

Takeda Pharmaceutical Company Limited 28

Macroeconomic Indicators 31

Country Data 31

Methodology 33

Industry associations 34

Related MarketLine research 34

Appendix 35

About MarketLine 35

List of Tables

Table 1: Japan biotechnology industry value: $ billion, 201115(e)

Table 2: Japan biotechnology industry category segmentation: $ billion, 2015(e)

Table 3: Japan biotechnology industry geography segmentation: $ billion, 2015(e)

Table 4: Japan biotechnology industry value forecast: $ billion, 201520

Table 5: Astellas Pharma Inc.: key facts

Table 6: Astellas Pharma Inc.: key financials ($)

Table 7: Astellas Pharma Inc.: key financials (Â¥)

Table 8: Astellas Pharma Inc.: key financial ratios

Table 9: Daiichi Sankyo Co., Ltd.: key facts

Table 10: Daiichi Sankyo Co., Ltd.: key financials ($)

Table 11: Daiichi Sankyo Co., Ltd.: key financials (Â¥)

Table 12: Daiichi Sankyo Co., Ltd.: key financial ratios

Table 13: Mitsubishi Tanabe Pharma Corporation: key facts

Table 14: Mitsubishi Tanabe Pharma Corporation: key financials ($)

Table 15: Mitsubishi Tanabe Pharma Corporation: key financials (Â¥)

Table 16: Mitsubishi Tanabe Pharma Corporation: key financial ratios

Table 17: Takeda Pharmaceutical Company Limited: key facts

Table 18: Takeda Pharmaceutical Company Limited: key financials ($)

Table 19: Takeda Pharmaceutical Company Limited: key financials (Â¥)

Table 20: Takeda Pharmaceutical Company Limited: key financial ratios

Table 21: Japan size of population (million), 201115

Table 22: Japan gdp (constant 2005 prices, $ billion), 201115

Table 23: Japan gdp (current prices, $ billion), 201115

Table 24: Japan inflation, 201115

Table 25: Japan consumer price index (absolute), 201115

Table 26: Japan exchange rate, 201115

List of Figures

Figure 1: Japan biotechnology industry value: $ billion, 201115(e)

Figure 2: Japan biotechnology industry category segmentation: % share, by value, 2015(e)

Figure 3: Japan biotechnology industry geography segmentation: % share, by value, 2015(e)

Figure 4: Japan biotechnology industry value forecast: $ billion, 201520

Figure 5: Forces driving competition in the biotechnology industry in Japan, 2015

Figure 6: Drivers of buyer power in the biotechnology industry in Japan, 2015

Figure 7: Drivers of supplier power in the biotechnology industry in Japan, 2015

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Japan, 2015

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Japan, 2015

Figure 10: Drivers of degree of rivalry in the biotechnology industry in Japan, 2015

Figure 11: Astellas Pharma Inc.: revenues & profitability

Figure 12: Astellas Pharma Inc.: assets & liabilities

Figure 13: Daiichi Sankyo Co., Ltd.: revenues & profitability

Figure 14: Daiichi Sankyo Co., Ltd.: assets & liabilities

Figure 15: Mitsubishi Tanabe Pharma Corporation: revenues & profitability

Figure 16: Mitsubishi Tanabe Pharma Corporation: assets & liabilities

Figure 17: Takeda Pharmaceutical Company Limited: revenues & profitability

Figure 18: Takeda Pharmaceutical Company Limited: assets & liabilities

List of Tables

NA

List of Figures

NA

    Pricing

Quick Buy
Add to basket Enquire before buying

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports